Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).

被引：0
|
作者：
Cao, Di
Wang, Fu-Long
Li, Cong
Zhang, Rong-Xin
Wu, Xiao-Jun
Li, Liren
Lu, Zhen-Hai
Pan, Zhi-Zhong
Lin, Jun-zhong
Wu, Miaoqing
Liu, Yifan
Lv, Guangzhao
Li, Min
Wang, Chenyang
Li, Xi
Chen, Gong
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Burning Rock Biotech, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
213
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [1] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [2] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer (CRC).
    Zhou, Jian
    Yang, Jian
    Zhang, Zixiang
    Li, Ye
    Yi, Bin
    Tang, Yuchen
    Li, Dechun
    Li, Xiaozhe
    Peng, Di
    Li, Xi
    Wang, Yang
    Li, Haiyan
    Li, Bing
    Wang, Chenyang
    Zhu, Pengfei
    Chen, Longfei
    Wu, Shuailai
    Fang, Shuai
    Li, Chenxi
    Qiu, Fujun
    Chuai, Shannon
    Zhang, Zhihong
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [3] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in stage 1-3 colorectal cancer (CRC) in clinical practice
    Somer, B.
    Mehler, S.
    Hasenburg, A.
    Greene, H.
    Tauer, K.
    Grothey, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S347 - S347
  • [5] Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.
    Chen, Gong
    Zeng, Yongming
    Feng, Chunzai
    Yang, Jingge
    Cheng, Longqing
    Wang, Hui
    Xia, Ligang
    Jiang, Mei
    Wang, Xiaozhong
    Zeng, Xiaoling
    Tian, Zihan
    Fu, Ning
    Zhang, Xue
    Cao, Wuqiang
    Li, Pansong
    Gao, Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 48 - 48
  • [6] Feasibility of tumor-informed circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment in pediatric patients with solid tumors.
    Mitchell, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer
    Emiloju, Oluwadunni E.
    Storandt, Michael
    Zemla, Tyler
    Tran, Nguyen
    Jethwa, Krishan
    Mahipal, Amit
    Mitchell, Jessica
    Thiels, Cornelius
    Mathis, Kellie
    McWilliams, Robert
    Hubbard, Joleen
    Sinicrope, Frank
    Shi, Qian
    Jin, Zhaohui
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
  • [8] Tumor-informed circulating tumor DNA (TI-ctDNA) based molecular residual disease (MRD) detection and relapse risk for patients with stage II-IV melanoma in surgical remission: A single center experience
    Rhea, Logan
    Daniels, Megan
    Sabo, Roy
    Poklepovic, Andrew Stewart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.
    Wang, Xiuchao
    Wang, Hongwei
    Chen, Xinyun
    Liu, Yuxiao
    Zhao, Tiansuo
    Gao, Song
    Wang, Jian
    Ma, Weidong
    Gao, Chuntao
    Hao, Jihui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 744 - 744
  • [10] A tumor-informed, hybrid-capture based ctDNA assay for minimal residual disease (MRD) detection in colorectal cancer (CRC) patients after curative surgery
    Han, S-W.
    Heo, S.
    Lim, Y.
    Lee, W.
    Kim, H-P.
    Kim, S. Y.
    Bang, D.
    Park, K. J.
    Oh, S. T.
    Yoo, C. S.
    Kang, S-B.
    Kim, Y-J.
    Kim, T-Y.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S710 - S711
12345